Introduction
The mammalian hearing organ, the organ of Corti, is comprised of both mechanosensory hair cells (HCs) and nonsensory supporting cells (SCs), but the loss of HCs results in permanent hearing loss (Bohne et al., 1976; Hawkins et al., 1976; Kelley, 2007; Oesterle et al., 2008) . In contrast, nonmammalian vertebrates are capable of HC regeneration by either direct SC to HC transdifferentiation or SC mitosis followed by SC to HC transdifferentiation (termed mitotic regeneration), and subsequently recover hearing function (Corwin and Cotanche, 1988; Ryals and Rubel, 1988; Stone and Cotanche, 2007; Rubel et al., 2013) . Despite recent advances, mitotic regeneration in postnatal mammalian cochleae in vivo remains limited by both insufficient cell number and survival.
The canonical Wnt signaling pathway, mediated by ␤-catenin, is critical for proper development and maturation of the cochlea (Dabdoub et al., 2003; Ohyama et al., 2007; Jayasena et al., 2008; Munnamalai and Fekete, 2013; Shi et al., 2014) . In the chicken basilar papilla and the zebrafish lateral line, Wnt activation plays a key role in promoting SC proliferation in response to ototoxic insult and the subsequent generation of new HCs (Head et al., 2013; Jacques et al., 2014) . In the mouse, in vivo studies have shown that the expression of an active form of ␤-catenin only results in a transient proliferation response in Lgr5 ϩ cells using the Lgr5CreER mouse line, whereas new HCs are generated from Lgr5 ϩ cells using the Sox2CreER mouse line (Chai et al., 2012; Shi et al., 2013) . However, it is unclear whether Sox2 haploinsufficiency contributes to the differential responses observed between the two aforementioned mice lines.
Lgr5 is characterized as a stem cell marker in the intestine and the hair follicle (Oshima et al., 2001; Barker et al., 2007) . In the neonatal mammalian cochlea, Lgr5 is expressed in some nonsensory epithelial cells in the greater epithelial ridge (GER), the inner border cells (IBCs), the inner phalangeal cells (IPhCs), pillar cells, and the third row of Deiters' cells (DCs) (Fig. 1) Shi et al., 2012) . Isolated Lgr5 ϩ cells from the neonatal organ of Corti are able to both proliferate and transdifferentiate into HCs in vitro, and recent reports have linked Lgr5 ϩ cells to neonatal HC regeneration (Chai et al., 2012; Shi et al., 2012; Cox et al., 2014) . These data suggest that Lgr5 ϩ cells could represent progenitor-like cells in postnatal cochleae for regeneration.
The basic helix-loop-helix transcription factor, Atoh1, plays a key role in HC fate determination (Bermingham et al., 1999; Chen et al., 2002; Mulvaney and Dabdoub, 2012; Jarman and Groves, 2013; Jahan et al., 2015) , and its ectopic expression in neonatal SCs induces SC to HC transdifferentiation. However, it is a slow and inefficient process, with most cells failing to transdifferentiate (Ͻ150 new HCs per cochlea) (Zheng and Gao, 2000; Kelly et al., 2012; Liu et al., 2014) .
To achieve both proliferation and transdifferentiation in postnatal cochleae, we ectopically coexpressed a constitutively active form of ␤-catenin and Atoh1 in neonatal cochlear Lgr5 ϩ cells. We discovered that this combination acts synergistically on a subset of Lgr5 ϩ cells by inducing both proliferation and differentiation, with the formation of 1338.48 Ϯ 271.98 new HCs per cochlea, most of which survive to adulthood, thus illustrating an inherent heterogeneity that exists among the Lgr5 ϩ cells. Together, our studies provide a foundation for future research using combinatorial therapeutics for mitotic regeneration in mammals for hearing restoration efforts.
Materials and Methods

Mice. Lgr5
EGFP-CreERT2/ϩ and PLP/CreER Tϩ mice were purchased from the The Jackson Laboratory (stock #008875 and #005975). Conditional Lgr5 deletion (Lgr5 fl/ϩ ) mouse was obtained from Dr. Clevers (Hubrecht Institute, Utrecht, The Netherlands) and described previously (de Lau et al., 2011) . Hes5nLacZ mouse was obtained from Dr. Kageyama and described previously (Imayoshi et al., 2010) . Atoh1-HA mouse was described previously . Refer to the aforementioned references for details regarding the PCR genotyping. Tamoxifen (T5648-5G, Sigma; 3 mg/40 g body weight) was given by intraperitoneal injections at postnatal (P) day 0 (P0) and 1 (P1). Sample sizes were N ϭ 3-7 mice of either sex for each group (control and experimental) at each time point for all experiments (except for P42-P44 where N ϭ 2). All animal work conducted during the course of this study was approved by the Institutional Animal Care and Use Committee at St. Jude Children's Research Hospital and was performed according to National Institutes of Health guidelines.
Tissue preparation, immunofluorescence, and analysis. Isolated cochleae were fixed in 2% (v/v) PFA (Electron Microscopy Services) in PBS (P3813, Sigma) for 3-4 h at room temperature or at 4°C overnight, and subsequently washed in PBS (3 ϫ 5 min). Whole-mount preparations were performed as described previously . The following primary antibodies were used: anti-myosin-VII (rabbit, 1:200, 25-6790, Proteus Biosciences), anti-HA (rat,1:100, 11867423001, Roche), antiCtbp2 (mouse,1:500, 612044, BD Transduction Laboratories), anti-GFP (chicken, 1:1000, ab13970, Abcam), anti-GluR2 (mouse, 1:200, MAB397, Millipore), anti-prestin (goat, 1:200, sc-22692, Santa Cruz Biotechnology), anti-Sox2 (goat, 1:1000, sc-17320, Santa Cruz Biotechnology), vGlut3 (rabbit, 1:500, 135203, Synaptic Systems), and anti-Tuj1 (mouse, 1:1000, MMS-435P, Covance). All secondary antibodies were purchased from Invitrogen and used at 1:1000, except for AlexaFluor-405 goat anti-rabbit IgG and AlexaFluor-647 goat anti-rat IgG (1:500). BrdU detection was achieved using AlexaFluor-647-conjugated antibody (mouse, 1:20, B35133, Invitrogen) . Confocal imaging was performed on a Zeiss LSM 700 or 710, and image processing was performed with Photoshop CS6 (Adobe Systems).
Quantification of ectopic HCs. Cochleae were cut into two parts with the cut site close to the end of the first apical turn. The apical, middle, and base regions were first imaged Ͻ20ϫ to identify regions of interest, and at least two Z-stacks from nonoverlapping regions were then obtained for each turn using the 40ϫ objective (1 m step). For each genotype and age, at least 3 cochleae from different mice were analyzed using Zeiss LSM image browser. We determined the number of ectopic HCs by scoring HA ϩ and HA ϩ /Myosin7a ϩ cells along the z-axis and determined the average number of cells per 300 m section based on an average measured cochlear length of 5.4 mm (from P8 and P21 whole mounts).
RNA isolation and real-time PCR. A minimum of 3 littermates from at least 2 litters were assayed. Pups were killed by decapitation, and the ears were dissected in ice-cold HBSS. RNA was isolated using the RNAqueous-Micro RNA Isolation Kit (Ambion). cDNA was generated using Superscript First-Strand cDNA Synthesis system for RT-PCR (Invitrogen) with random primers. Relative expression levels were assayed using TaqMan Gene Expression Master Mix and TaqMan probes (Applied Biosystems) for Notch1, Sox2, Jagged1, Delta-like 1, and 18S. Reactions were run in triplicate in an Eppendorf Realplex 2 Mastercycler System, which has a C T cutoff value of 40. In our analysis, we set the upper most limit of C T at 38 to be included in the analysis. Each sample was run in triplicate on each plate, and each sample was also run on multiple plates to ensure the validity of the results. The level of 18S was used as an internal control and was run as a multiplex reaction with each assayed gene. The difference in C T between the assayed gene and 18S for any given sample was defined as ⌬C T(X) . The difference in ⌬C T(x) between two samples was defined as ⌬⌬C T(X) , which represents a relative difference in expression of the assayed gene. The fold change of the assayed gene relative to 18S was defined as 2
Ϫ⌬⌬CT (Livak and Schmittgen, 2001 ). DataAssist software (Applied Biosystems) was used for statistical analysis and to confirm ⌬C T(X) calculation.
Statistical analysis. Statistical analysis was performed using the GraphPad Prism 5.0 (Graphpad Software). Nonparametric Student's t test with Bonferroni correction or two-way ANOVA with Bonferroni correction (for auditory brainstem response [ABR] measurements) was used to determine statistical significance.
Results
␤-Catenin and Atoh1 synergistically increase the proliferation of Lgr5
؉ cells Our group and others have previously shown that in vivo expression of a constitutively active form of ␤-catenin in neonatal cochlear Lgr5 ϩ cells results in a transient proliferative response with the formation of replication foci closely abutting the inner HCs (IHCs) (Chai et al., 2012; Shi et al., 2013) . However, unlike cultured Lgr5 ϩ cells (Chai et al., 2012) , this induction paradigm did not generate new HCs in vivo. Atoh1 is critical for normal HC differentiation (Bermingham et al., 1999; Chen et al., 2002; Dabdoub et al., 2003; Mulvaney and Dabdoub, 2012; Jarman and Groves, 2013; Jahan et al., 2015) ; and because its ectopic expression induces the transdifferentiation of SCs in vivo, we generated ;CAG-loxP-Stop-loxP-Atoh1-HA mice (thereafter refer to as Lgr5CreER;␤-catenin;HAϩ) to induce the transdifferentiation of ␤-catenin-induced proliferating Lgr5 ϩ cells. The HA tag in the Atoh1-HA transgenic mice allowed for lineage tracing and provides a way to distinguish between ectopic and endogenous Atoh1 expression . We first assessed the effect of this combination on proliferation by performing a BrdU pulse-chase experiment. Tamoxifen induction was first performed at postnatal day 0 and 1 (P0-P1), followed by intraperitoneal injections of BrdU (4 injections 2 h apart) at P4. (Tables 1, 2 ). Of note, the number of HA Ϫ /BrdU ϩ cells is unexpectedly higher compared with the number of HA ϩ /BrdU ϩ cells, which suggests the potential of a non-cell-autonomous affect via the recruitment of Cre-negative cells to the foci without subsequent proliferation. However, given that all cells in the foci were GFP ϩ (Cre ϩ ) in our previous study (Chai et al., 2012) , this scenario is unlikely and we attribute this lower than expected number of HA ϩ /BrdU ϩ cells to the low sensitivity of the HA antibody instead. Nonetheless, we conclude that ␤-catenin and Atoh1 act synergistically on the proliferation of Lgr5 ϩ cells. We next performed whole-mount analyses as described previously (Chai et al., 2012) , with tamoxifen induction at P0-P1, and samples collected at P8, P15, and P21. The results show that replication foci (we use this term based on the results from the BrdU pulse-chase experiments) formed in Lgr5CreER;␤-catenin;HA ϩ and Lgr5CreER;␤-catenin mice, but not in Lgr5CreER;HA ϩ mice. The proliferation response was transient in both ␤-catenin ectopic expression models (the foci are no longer present at P21; Fig. 2 F, L) , but the replication foci were larger with poorly defined boundaries at P8 (Fig. 2D ) and P15 ( Fig. 2H ) in Lgr5CreER;␤-catenin;HA ϩ mice compared with Lgr5CreER;␤-catenin mice (Chai et al., 2012) (Fig. 2 B, F ) . Nonetheless, these results further support that the combination of ␤-catenin and Atoh1 synergistically increases the proliferation response in Lgr5CreER;␤-catenin;HA ϩ mice, compared with Lgr5CreER;␤-catenin mice. 
Lgr5
؉ cells expressing ␤-catenin and Atoh1 give rise to new HCs Because the proliferation response in Lgr5CreER;␤-catenin;HA ϩ mice is increased, we next determined whether the coexpression of ␤-catenin and Atoh1 resulted in the transdifferentiation of proliferating Lgr5 ϩ cells into HCs, using the Atoh1-HA-tag for lineage-tracing. At P8, new HCs expressing both the HA tag and Myosin7a (thereafter referred to as HA ϩ /Myo7a ϩ HCs) were present in the IHC region along the cochleae of Lgr5CreER;HA ϩ mice (Fig. 2C, arrowhead) , whereas new HCs in both the IHC and outer HC (OHC) regions along the cochleae (Fig. 2D , arrowheads and arrow, respectively) were present in Lgr5CreER;␤-catenin; HA ϩ mice. The HA ϩ /Myo7a ϩ HCs were still present in the IHC and OHC regions at P15 (Fig. 2G ,H ) and P21 ( Fig. 2 K, L) . There was no significant difference in new HC numbers between cochlear turns (Student's t test with Bonferroni correction).
Because no new HCs formed in Lgr5CreER;␤-catenin mice (Chai et al., 2012; Shi et al., 2013) Tϩ ; Atoh1-HA ϩ mice also induced at P0-P1 . This difference is most likely because Lgr5 is expressed in more nonsensory epithelial cells (GER, IBCs, and IPhCs) than in the PLP/CreER Tϩ model (IPhCs and IBCs only) (Fig. 1) .
Because Lgr5CreER;␤-catenin;HA ϩ mice have severely reduced body size and a high mortality rate (ϳ80%), which is likely due to detrimental effects on the intestinal lining, this greatly limited our long-term studies. Nonetheless, we managed to analyze two mice that survived to P42-P44 and observed an average of 28.60 Ϯ 1.00 HA ϩ /Myo7a ϩ new HCs per 300 m cochlear section or 514.80 Ϯ 18.00 new HCs per cochlea at P42-P44 (Fig. 3 J, K ) , indicating that the new HCs that were observed at P21 survived up to those ages. Furthermore, HA ϩ /Myo7a ϩ /BrdU ϩ cells from animals that received BrdU at P4 (immunoprecipitation injections, 4 injections 2 h apart) were also present at P21 (18 Ϯ 10 cells per 300 m section) (Fig. 3L, arrowhead) , suggesting that they were derived from proliferating and transdifferentiating Lgr5 ϩ cells that coexpress ␤-catenin and Atoh1-HA.
We analyzed the effect of ␤-catenin and Atoh1-HA on the transdifferentiation of the third row of Deiters' cells (Fig. 1A , dotted lined, B, SC-labeled DC3). We observed the formation of new HCs by P8 (Fig. 2D, arrow) , which is in contrast to the Prox1CreER T2ϩ ;Atoh1-HA mouse line reported previously, where the transdifferentiation of similar SCs did not occur until P22 . HA ϩ and HA ϩ /Myo7a cell counts (Table 5) showed no significant differences (statistical significance was assessed by Student's t test with Bonferroni correction) between Lgr5CreER;␤-catenin;HA ϩ and Lgr5CreER;HA ϩ mice. We conclude that, although the ectopic expression of ␤-catenin and Atoh1-HA accelerated the transdifferentiation of the third Deiters's cells, it had little to no effect on proliferation or conversion efficiency of these cells.
Lgr5-derived HCs from ␤-catenin and Atoh1-HA ectopic expression remain immature
To address the level of maturation of the new HCs, we analyzed the expression of various HC markers and synaptic components at P21 in Lgr5CreER;␤-catenin;HA ϩ mice. The new HCs express the following HC markers: otoferlin (Fig. 3B, arrowheads) , Myosin7a (Fig. 3B, arrowheads , DЉ, asterisk) and parvalbumin (Fig. 3C, arrowheads) , but do not express the mature/terminal IHC marker, vGlut3 (Fig. 3C, arrowheads) or the mature/terminal OHC marker, prestin, in either the IHC or OHC regions, while retaining a 2.09 Ϯ 0.38-fold increase in Sox2 expression compared with control littermates ( p ϭ 3.04 E-09; df ϭ 46;n ϭ 4 using a Student's t test with Bonferroni correction) (see Fig. 5H ). The persistence of Sox2 is consistent with a previous study using the Atoh1-HA mouse line . The new HCs remained immature even at P44 (Fig. 3K ) .
The new HCs closely abutting the endogenous IHCs were innervated as shown by the presence of Tuj1 ϩ projection on their basolateral side (Fig. 3 D, DЈ , arrowheads, where the asterisk denotes the new HC), and also expressed the presynaptic ribbon component, C-terminal binding protein 2 (Ctbp2) (Fig. 3F 1 Ј,  arrowheads) , as well as the postsynaptic marker glutamate receptor type 2 (GluR2) (Fig. 3F 1 Љ, arrowheads) . However, there was some incomplete overlap/match of Ctbp2 and GluR2 pu- in D) . D-D؆, Asterisk indicates the ectopic HC. In the endogenous IHCs, the synaptic markers Ctbp2 and GluR2 are both expressed in a matching pattern (arrowheads in F2 and F2؆, respectively). In the new HCs, some GluR2 puncta overlap with Ctbp2 puncta (arrowheads in F1 and F1؆, respectively), whereas others do not (open arrowhead in F1 and F1؆, respectively) . G, The hair bundles form in the new HCs abutting the IHCs (green arrowheads in G), but their morphology differs from that of the endogenous IHCs (white arrowheads in G) and OHCs (red arrowheads in G). H, Phalloidin staining of the IHC region from G. Relative to the endogenous HCs (H 1 ), the medially located new HCs display bent (H 2 ), splayed (H 3 ), or perpendicular morphology (H 4 ). I, The ectopic HCs located in the OHC region (white arrowhead in I and I) also display a peculiar hair cell bundle morphology, which does not resemble that of the traditional "V" shape found in normal endogenous OHCs (red arrowheads in I ). I-I؆, Cross-sectional view in which there is accumulation of actin at the cuticular plate in the endogenous (red arrowheads in I) and ectopic HCs (white arrowhead in I). J, K, New HCs are still present at P42-P44 (514.8 Ϯ 18 per cochlea). Immunostaining of otoferlin (blue), Lgr5-EGFP (green), Atoh1-HA (red), Myosin7a (white in J ), and vGlut3 (white in K ) in the cochlea of a Lgr5CreER;␤-catenin;HA ϩ mouse at P42-P44. L, New HCs generated from ␤-catenin and Atoh1 with BrdU pulse at P4 is still present at P21. M, ABR thresholds (Ϯ SEM) from P21 animals. Scale bars, 25 m. Scale bars: D, D؆, E, E؆, H 1 -H 4 , I-I؆, 10 m; F, 5 m; F 1 , F 2 ؆, 2 m. *p Ͻ 0.05 (two-way ANOVA with Bonferroni correction). ***p Ͻ 0.0001 (two-way ANOVA with Bonferroni correction). Refer to text for actual p values. N ϭ 9 (control: ␤-catenin;HA ϩ ) and N ϭ 6 (Lgr5CreER; ␤-catenin;HA ϩ ).
ncta ( Fig. 3F 1 Ј,F 1 Љ, open arrowheads, for Ctbp2 and GluR2, respectively). Stereocilia were present at the apical surface of the new HCs located in the IHC region (Fig. 3G, green arrowheads) , but their morphology differed from that of endogenous IHCs and OHCs (Fig. 3G , white and red arrowheads, respectively). We observed 3 types of stereocilia morphology relative to the endogenous HCs (Fig. 3H 1 ) : bent (Fig. 3H 2 ) , splayed (Fig. 3H 3 ) , and perpendicular ( Fig. 3H 4 ) . Finally, the new HCs derived from the third row of Deiters' cells formed stereocillia as reflected by the accumulation of actin at the cuticular plate ( Fig. 3I and white arrowhead for the new HCs vs red arrowheads for the endogenous HCs in Fig.  3 I, IЈ) . Auditory brainstem responses (ABR) measurements at P21 from Lgr5CreER;␤-catenin;HA ϩ mice show significant higher hearing thresholds than littermate control mice (two-way ANOVA: 4 kHz: p ϭ 0.293,df ϭ 78; 6, 12, 16, 22, 32 kHz: p Ͻ 0.0001,df ϭ 78) (Fig. 3M ) . This is consistent with our previous studies where the addition of immature new HCs resulted in elevated hearing thresholds . Together, these data indicate that the new HCs express some HC markers and synaptic components, are innervated, and contain stereocilia bundles. However, these cells remain immature and their presence results in elevated ABR thresholds.
Only a subset of Lgr5
؉ cells proliferate and differentiate in response to ␤-catenin and Atoh1 expression To assess the potential heterogeneity among Lgr5 ϩ cell populations, we used another independent inducible Cre line, PLP/Cre-ER Tϩ at P0-P1 (Gó mez-Casati et al., 2010; Liu et al., 2014) . PLP/ CreER Tϩ targets the two SC subtypes directly abutting the IHCs, the IPhCs and IBCs (Fig. 1C) , whereas Lgr5CreER targets a broader range of nonsensory epithelial cell subtypes (Fig. 1B) but includes the IPhCs and IBCs (Fig. 1B) . Unlike the Lgr5CreER;␤-catenin mice, we did not observe the formation of replication foci at P8 or P21 in any of the 3 genotypes generated: PLP/CreER T/ϩ ; ␤-catenin (Fig. 4 B, F Fig. 4 D, H T/ϩ -mediated deletion of exon 3 in the ␤-catenin allele with the successful detection of the WT and the exon3-deleted ␤-catenin alleles in cochleae-extracted DNA by PCR from PLP/CreER T/ϩ ;␤-catenin mice (Fig. 4I , WT and ⌬ex3) as described by Harada et al. (1999) . It may be of interest to note that we did observe differences in the number of ectopic HA ϩ / Myo7a ϩ cells in PLP/CreER T/ϩ ;HA ϩ compared with a previous study , and these differences are likely due to variation between the mixed background strains used for the different studies or differences in sample processing for fixation and HA antibody labeling.
We next asked whether Lgr5 haploinsufficiency could contribute to the absence of proliferation in the PLP/CreER fl/ϩ mice. In these mice, we were unable to detect a proliferative response as reflected by the lack of IHC displacement at P8 (Fig. 4 K, L) , which we typically observed in the Lgr5CreER;␤-catenin mice (Fig. 2) . Therefore, this indicates that Lgr5 haploinsufficiency does not have a significant role in preventing Wnt mediated mitogenic effect on the IBCs/IPhCs, but rather that the IBCs/IPhCs are unresponsive to ectopic Wnt signaling. The lack of a GER-specific CreER mouse line further prevented us from testing the impact of Lgr5 haploinsufficiency on the proliferative response in these cells. Together, these data indicate that the Lgr5 ϩ , but PLP/CreER-negative nonsensory epithelial cells located medially to the IBCs or IPhCs in the GER region, are responsible for the synergistic proliferation and differentiation responses mediated by ectopic ␤-catenin and Atoh1 expression. 
Notch upregulation by ␤-catenin is abrogated by ␤-catenin and Atoh1 in Lgr5
؉ cells To address the potential mechanism underlying the synergistic effect of ␤-catenin and Atoh1-HA on the proliferation and differentiation of Lgr5 ϩ cells, we focused on the Notch signaling pathway because it has been shown to regulate both ␤-catenin and Atoh1 (Lanford et al. downstream effectors (Jarriault et al., 1995; Kageyama and Ohtsuka, 1999; Ohtsuka et al., 1999) involved in HC differentiation (Zine et al., 2001; Zine and de Ribaupierre, 2002; Tateya et al., 2011) . We observed the presence of Hes5 ϩ cells in Lgr5CreER;␤-catenin; Hes5nLacZ mice (Fig. 5B , arrowhead) compared with control mice (Fig. 5A ). This suggests that Notch signaling is indeed activated by the canonical Wnt signaling effector, ␤-catenin, in the organ of Corti, when it is normally downregulated during the first week of postnatal development (Hartman et al., 2009; Maass et al., 2015) . In contrast, there were very few Hes5 ϩ cells in Lgr5CreER;HAϩ; Hes5nLacZ and Lgr5CreER;␤-catenin; HA ϩ ;Hes5nLacZ mice (Fig.  5C,D) .
In support of the observed ␤-catenin-mediated Notch activation (see above), we analyzed the expression of Notch1 since it has been implicated in cochlear development (Lanford et al., 1999; Zine et al., 2000) . We analyzed Notch1 expression by qPCR analysis (C T values included in Fig. 5 legend) of P8 microdissected organ of Corti and found a significant increase in Notch1 expression in Lgr5CreER;␤-catenin ϩ mice compared with littermate controls (2.33 Ϯ 0.67 (n ϭ 3); p ϭ 0.001; df ϭ 36 using a Student's t test with Bonferroni correction) (Fig. 5E ), further supporting the notion that Wnt activation results in Notch activation. However, Notch1 expression is significantly decreased in Lgr5CreER;␤-catenin; HA ϩ mice compared with Lgr5CreER;␤- catenin ( p ϭ 0.0068; df ϭ 39 using a Student's t test with Bonferroni correction) (Fig. 5E ). We also analyzed the expression of Notch1 ligands, Jagged 1 (Fig. 5F ) and Delta-like 1 (Fig. 5G) and found no significant differences between all genotypes (statistical significance was assessed by Student's t test with Bonferroni correction). Nonetheless, these data combined with the Hes5nlacZ results ( Fig. 5A-D) suggest that Notch activation mediated by ␤-catenin is inhibited by the ectopic expression of Atoh1 in Lgr5 ϩ cells, which may play a role in the synergistic effects that we described earlier. Understanding these opposing roles of Notch and Atoh1 in the inner ear warrants future investigation.
Discussion
In vivo HC regeneration in postnatal mammalian cochleae has been hampered by limited differentiation efficiency and spontaneous mitotic regeneration, and subsequent cell death of regenerated HCs (ranging from 12 to 150 new HCs generated per cochlea) (Kelly et al., 2012; Liu et al., 2012; Mizutari et al., 2013; Shi et al., 2013; Cox et al., 2014; Liu et al., 2014 (Ou et al., 2000) . Moreover, most of these new HCs survive to adulthood with 514.80 Ϯ 18.00 new HCs per cochlea remaining at P42-P44. Our study is the first to achieve substantial proliferation and transdifferentiation in a mammalian cochleae in vivo, which parallels the efficient mitotic HC regeneration found in nonmammalian vertebrates and therefore represents a significant advancement for in vivo generation of new auditory HCs in a mammalian system. ␤-Catenin has been shown to positively regulate the expression of Atoh1 (Shi et al., 2010 (Shi et al., , 2013 , so the absence of no new HCs generated in Lgr5CreER;␤-catenin ϩ mice was puzzling (Chai et al., 2012; Shi et al., 2013) . Because ␤-catenin promotes Notch activation in Lgr5CreER;␤-catenin ϩ mice, we therefore attributed the absence of new HCs to Notch repression on ␤-catenin and presumed ␤-catenin-mediated Atoh1 activation. Indeed, Notch has been reported to post-translationally repress ␤-catenin activity (Kwon et al., 2011; Kim et al., 2012) , and this further suggests the existence of a negative feedback loop to limit ␤-catenin activity to possibly prevent uncontrolled growth as observed in various cancers (Reya and Clevers, 2005) . In addition, there is evidence that Hes family members, including Hes5, repress HC differentiation via Atoh1 repression in both auditory sensory epithelia and other tissues (Lanford et al., 2000; Zheng et al., 2000; Zine and de Ribaupierre, 2002; Takebayashi et al., 2007; Sikandar et al., 2010; VanDussen et al., 2012; Petrovic et al., 2014) . Because we observed a decrease in Notch signaling with the synergistic effects of ␤-catenin and Atoh1-HA on proliferation and transdifferentiation in Lgr5 ϩ cells in Lgr5CreER;␤-catenin;HA ϩ compared with Lgr5CreER;␤-catenin, this suggests a repressive role for Atoh1 on Notch signaling (incidentally activated by ␤-catenin). Repression of Notch would presumably promote the ␤-catenin mitogenic effect and provide an indirect role on proliferation. This could possibly be through the modulation of Notch repressors (i.e., Numb, Fbxw7) or activators (i.e., Rbpj or Mastermind) (for review, see Ranganathan et al., 2011) (Fig. 5I ) . Nonetheless, we speculate that the ectopic expression of the Atoh1-HA transgene in Lgr5CreER;␤-catenin;HA ϩ abrogates the ␤-catenin-mediated Notch repression of endogenous Atoh1 and ␤-catenin. Furthermore, the ectopic expression of Atoh1 likely increases the levels of endogenous Atoh1, closer to a threshold from which the nonsensory epithelial cells can undergo HC differentiation. Consequently, this leads to an increase in ␤-cateninexpressing SCs competent to respond to pro-HC differentiation cues regulated by ectopic Atoh1. Of note, a recent report described the importance of Notch repression in the context of Wnt-dependent proliferation and HC generation in Sox2 ϩ and Lgr5 ϩ cells, which is largely consistent with our results (Li et al., 2015) . Although the aforementioned report described an increase in Wnt signaling that promotes mitotic HC generation after Notch deletion alone, we attribute such discrepancy to several factors, including the use of Sox2CreER line in vivo, explant cultures for Lgr5CreER;Notch1 f/f , and/or the use of use of ␥-secretase inhibitors, which could affect additional signaling pathways. Nonetheless, Notch inhibition, through ␥-secretase inhibitors, has been described to promote HC formation and maturation in the damaged cochlea (Korrapati et al., 2013; Mizutari et al., 2013; Bramhall et al., 2014) , thus highlighting the impact of this pathway on HC regeneration. Together, we conclude that the combination of ␤-catenin and Atoh1 provides a platform from which to promote proliferation and differentiation of SCs, although this paradigm still requires further manipulation(s) for terminal maturation.
Although we describe an indirect role for Atoh1 on proliferation, via Notch repression, targetome analyses provide an extensive list of Atoh1-associated cellular processes (e.g., transcription, proliferation, migration, cytoskeletal rearrangements) Yoon et al., 2011; Cai et al., 2015) . This suggests that Atoh1 is involved in other cellular events, which may also influence the synergistic effect observed in our model, although these cellular processes are also likely affected by ␤-catenin, especially in the context of proliferation.
Cellular heterogeneity has been shown for the Lgr5 ϩ cells in the intestine, whereby only 5% of isolated Lgr5 ϩ cells give rise to organoid (Sato et al., 2009) , and lineage-tracing experiments have shown that only high GFP-expressing Lgr5 ϩ cells exhibit clonal expansion capability (Snippert et al., 2010) . Our results are consistent with this notion since. For instance, there is an absence of synergic effect on the proliferation and transdifferentiation rate in the third row of Deiters' cells, and in a subset of Lgr5 ϩ cells, the IPhCs and IBCs. For the former, we attribute the lack of synergy to the presumed high Lgr5 expression (reflected by EGFP expression) in these cells , which could prevent their proliferation and transdifferentiation. In support, the new HCs generated in this study and those derived from isolated Lgr5 ϩ cells cultured in the presence of Wnt3a no longer express EGFP (Chai et al., 2012) . For the latter, we conjecture that IPhCs and IBCs may respond differently to ␤-catenin and Atoh1 compared with other Lgr5 ϩ nonsensory epithelial cells, possibly because the endogenous ␤-catenin promoter may already be downregulated at the time of induction. This is important because the activation of the ␤-catenin allele used in this study is dependent upon the endogenous ␤-catenin promoter (Harada et al., 1999) . In this scenario, Lgr5-EGFP expression could merely reflect residual Wnt activity because Lgr5 expression is normally downregulated in IPhCs and IBCs during the first postnatal week. This inherent cellular heterogeneity within the Lgr5 ϩ cells is also supported by other studies Shi et al., 2013) . Regardless, because the Lgr5 ϩ cells are thought to be the stem/ progenitor cells of the neonatal cochlea with higher proliferation and differentiation potential than the broader population of p27
Kip1ϩ cells (White et al., 2006), these cells remain of high interest for hearing restoration efforts.
